应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01349 复旦张江
已收盘 02-23 15:52:54
3.230
+0.000
0.00%
最高
3.230
最低
3.170
成交量
10.80万
今开
3.190
昨收
3.230
日振幅
1.86%
总市值
33.50亿
流通市值
10.53亿
总股本
10.37亿
成交额
34.66万
换手率
0.03%
流通股本
3.26亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
复旦张江02月11日主力净流出37.1万元 散户资金买入
市场透视 · 02-11
复旦张江02月11日主力净流出37.1万元 散户资金买入
复旦张江:更换持续督导保荐代表人
证券日报 · 02-09
复旦张江:更换持续督导保荐代表人
复旦张江公布国际专利申请:“一种蒽环类化合物及其制备方法、中间体和应用”
证券之星 · 02-08
复旦张江公布国际专利申请:“一种蒽环类化合物及其制备方法、中间体和应用”
智通AH统计|2月5日
智通财经 · 02-05
智通AH统计|2月5日
复旦张江02月02日主力净流出21.7万元 散户资金买入
市场透视 · 02-02
复旦张江02月02日主力净流出21.7万元 散户资金买入
港股异动 | 复旦张江(01349)盘中跌4% 预计2025年由盈转亏最多1.8亿元
智通财经 · 02-02
港股异动 | 复旦张江(01349)盘中跌4% 预计2025年由盈转亏最多1.8亿元
荣昌生物、科兴制药、君实生物等多家创新药企2025业绩战况如何?
制药网 · 02-02
荣昌生物、科兴制药、君实生物等多家创新药企2025业绩战况如何?
复旦张江2025年业绩预告,攻坚ADC与光动力
和讯网 · 02-02
复旦张江2025年业绩预告,攻坚ADC与光动力
复旦张江(01349)发盈警 预计2025年度归母净亏损约1.2亿至1.8亿元
智通财经 · 01-30
复旦张江(01349)发盈警 预计2025年度归母净亏损约1.2亿至1.8亿元
复旦张江(688505)披露盐酸氨酮戊酸口服溶液用粉末获上市申请受理通知书,1月29日股价下跌0.68%
证券之星 · 01-29
复旦张江(688505)披露盐酸氨酮戊酸口服溶液用粉末获上市申请受理通知书,1月29日股价下跌0.68%
复旦张江最新公告:盐酸氨酮戊酸口服溶液用粉末用于脑胶质瘤手术可视化获得药物上市申请受理通知书
证券之星 · 01-29
复旦张江最新公告:盐酸氨酮戊酸口服溶液用粉末用于脑胶质瘤手术可视化获得药物上市申请受理通知书
复旦张江01月28日主力净流出186.8万元 散户资金买入
市场透视 · 01-28
复旦张江01月28日主力净流出186.8万元 散户资金买入
智通AH统计|1月27日
智通财经 · 01-27
智通AH统计|1月27日
港股异动 | 部分医药股午后拉升 康希诺生物(06185)超10% 君实生物(01877)涨超5%
智通财经 · 01-26
港股异动 | 部分医药股午后拉升 康希诺生物(06185)超10% 君实生物(01877)涨超5%
部分银行黄金存款被抢光
21世纪经济报道 · 01-22
部分银行黄金存款被抢光
泰州复旦张江旗下产品LED光动力治疗仪拿到国家药监局审批的二类证
动脉网 · 01-22
泰州复旦张江旗下产品LED光动力治疗仪拿到国家药监局审批的二类证
智通AH统计|1月19日
智通财经 · 01-19
智通AH统计|1月19日
每周股票复盘:复旦张江(688505)股东减持1036万股占总股本1.00%
证券之星 · 01-18
每周股票复盘:复旦张江(688505)股东减持1036万股占总股本1.00%
股市必读:1月13日复旦张江发布公告,股东减持794.88万股
证券之星 · 01-14
股市必读:1月13日复旦张江发布公告,股东减持794.88万股
复旦张江:杨宗孟已减持1.00%股份
南方财经网 · 01-13
复旦张江:杨宗孟已减持1.00%股份
暂无数据
公司概况
公司名称:
复旦张江
所属市场:
SEHK
上市日期:
--
主营业务:
上海复旦张江生物医药股份有限公司是一家主要从事生物医药的研究开发、生产制造和市场营销业务的中国公司。该公司的产品包括盐酸氨酮戊酸外用散(商品名:艾拉)和注射用海姆泊芬(商品名:复美达),以及盐酸多柔比星脂质体注射液(商品名:里葆多)。其产品主要用于皮肤性病治疗和抗肿瘤治疗。该公司在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01349","market":"HK","secType":"STK","nameCN":"复旦张江","latestPrice":3.23,"timestamp":1771833174136,"preClose":3.23,"halted":0,"volume":108000,"delay":0,"changeRate":0,"floatShares":326000000,"shares":1036999999,"eps":0.038332,"marketStatus":"已收盘","change":0,"latestTime":"02-23 15:52:54","open":3.19,"high":3.23,"low":3.17,"amount":346620,"amplitude":0.018576,"askPrice":3.23,"askSize":1000,"bidPrice":3.17,"bidSize":19000,"shortable":0,"etf":0,"ttmEps":-0.066,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"adr":0,"listingDate":1029168000000,"exchange":"SEHK","adjPreClose":3.23,"nav":14475,"aum":448017213600,"dividendRate":0.009907,"bidAskSpread":0,"openAndCloseTimeList":[[1771810200000,1771819200000],[1771822800000,1771833600000]],"volumeRatio":0.091776,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688505","market":"SH","secType":"STK","nameCN":"复旦张江","latestPrice":8.62,"timestamp":1770966000000,"preClose":8.74,"halted":0,"volume":4367000,"delay":0,"premium":"-67.00"}},"requestUrl":"/m/hq/s/01349/tweets","defaultTab":"tweets","newsList":[{"id":"2610959230","title":"复旦张江02月11日主力净流出37.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2610959230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610959230?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:15","pubTimestamp":1770797738,"startTime":"0","endTime":"0","summary":"02月11日, 复旦张江股价跌2.40%,报收3.25元,成交金额789.0万元,换手率0.73%,振幅4.20%,量比0.53。复旦张江今日主力资金净流出37.1万元,上一交易日主力净流入228.9万元。该股近5个交易日上涨3.49%,主力资金累计净流入66.4万元;近20日主力资金累计净流入188.7万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211161823a6ee0b38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211161823a6ee0b38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01349"],"gpt_icon":0},{"id":"2610763721","title":"复旦张江:更换持续督导保荐代表人","url":"https://stock-news.laohu8.com/highlight/detail?id=2610763721","media":"证券日报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610763721?lang=zh_cn&edition=full","pubTime":"2026-02-09 20:08","pubTimestamp":1770638933,"startTime":"0","endTime":"0","summary":"证券日报网讯2月9日,复旦张江发布公告称,公司首次公开发行股票并在科创板上市项目(以下简称“本项目”)的保荐机构为国泰海通证券股份有限公司(以下简称“国泰海通”),本项目法定持续督导期间为2020年6月19日至2023年12月31日,郑干国先生、陈恒瑞先生为本项目持续督导期间的保荐代表人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602093645633736.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","01349","BK0239","688505"],"gpt_icon":0},{"id":"2609521885","title":"复旦张江公布国际专利申请:“一种蒽环类化合物及其制备方法、中间体和应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2609521885","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609521885?lang=zh_cn&edition=full","pubTime":"2026-02-08 05:39","pubTimestamp":1770500362,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示复旦张江(688505)公布了一项国际专利申请,专利名为“一种蒽环类化合物及其制备方法、中间体和应用”,专利申请号为PCT/CN2025/112113,国际公布日为2026年2月5日。专利详情如下:图片来源:世界知识产权组织(WIPO)今年以来复旦张江已公布的国际专利申请1个。结合公司2025年中报财务数据,2025上半年公司在研发方面投入了1.78亿元,同比增15.13%。数据来源:企查查以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800001427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","01349","688505","BK1191"],"gpt_icon":0},{"id":"2609632452","title":"智通AH统计|2月5日","url":"https://stock-news.laohu8.com/highlight/detail?id=2609632452","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609632452?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:15","pubTimestamp":1770279306,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止2月5日收盘,东北电气、浙江世宝、中石化油服分列AH溢价率前三位,溢价率分别为815.25%、354.93%、295.40%;宁德时代、招商银行、恒瑞医药分列AH溢价率末三位,溢价率分别为-11.82%、-2.30%、1.62%。其中金风科技、金隅集团、中石化油服的偏离值位居前三,分别为21.73%、19.04%、18.76%;另外,浙江世宝、钧达股份、长飞光纤光缆的偏离值位居后三,分别为-41.23%、-39.46%、-26.61%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402034.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02338","00323","03750","01033","06031","PNGAY","82318","00187","02465","02579","03606","00042","01276","02318","PAImain","601318","HPAD.SI","00038","159982","00638","01057","03145","02865","LU0650527681.SGD","02359","399300","01349","IE00BGHQDM52.EUR","IE00B3M56506.USD","01108","09696","02691","LU2279701549.SGD","00553","03968","00300","03143","BK1523","02883","06690","02009","01528","03678","06869","09989","06613","02218","02628","02208"],"gpt_icon":1},{"id":"2608689675","title":"复旦张江02月02日主力净流出21.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2608689675","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608689675?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:15","pubTimestamp":1770020134,"startTime":"0","endTime":"0","summary":"02月02日, 复旦张江股价跌5.23%,报收3.08元,成交金额710.9万元,换手率0.70%,振幅4.92%,量比0.81。复旦张江今日主力资金净流出21.7万元,上一交易日主力净流入5.2万元。该股近5个交易日下跌5.52%,主力资金累计净流出161.7万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出204.7万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202161826a6c97226&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202161826a6c97226&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01349"],"gpt_icon":0},{"id":"2608360038","title":"港股异动 | 复旦张江(01349)盘中跌4% 预计2025年由盈转亏最多1.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608360038","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608360038?lang=zh_cn&edition=full","pubTime":"2026-02-02 11:11","pubTimestamp":1770001874,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,复旦张江盘中跌4%,截至发稿,跌3.69%,报3.13港元,成交额371.59万港元。消息面上,复旦张江公布,集团预计截至2025年12月31日止年度将取得未经审核的归属于母公司所有者的净亏损约为人民币1.2亿元至1.8亿元,2024年同期净利润为人民币3973.39万元;未经审核的归属于母公司所有者的扣除非经常性损益的净亏损约为人民币1.4亿元至2亿元,2024年扣除非经常性损益的净利润为人民币514.52万元。期内研发投入约3.5亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400426.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688505","BK1191","BK4588","VT","BK4585","01349"],"gpt_icon":0},{"id":"2608896737","title":"荣昌生物、科兴制药、君实生物等多家创新药企2025业绩战况如何?","url":"https://stock-news.laohu8.com/highlight/detail?id=2608896737","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608896737?lang=zh_cn&edition=full","pubTime":"2026-02-02 10:25","pubTimestamp":1769999139,"startTime":"0","endTime":"0","summary":"1月30日,包括荣昌生物、科兴制药、君实生物、百利天恒、复旦张江等多家创新药企业发布2025年业绩预告,那么2025年这些药企战绩如何?而科兴制药更是预计,2025年归母净利润同比增长328.83%至455.89%,为1.35亿元至1.75亿元。科兴制药表示,创新药管线突破奠定业绩增长基础。与荣昌生物、科兴制药的强势增长不同,百利天恒、复旦张江等则面临不同程度的业绩压力,但各有应对与布局。各家创新药企业的业绩表现,背后是2025年国产创新药行业的结构性改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202104016a6c84b5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202104016a6c84b5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","01877","06978","01349","LU1969619763.USD","BK1574","BK1191","BK1515","BK1161","09995","BK1583"],"gpt_icon":0},{"id":"2608535488","title":"复旦张江2025年业绩预告,攻坚ADC与光动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2608535488","media":"和讯网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608535488?lang=zh_cn&edition=full","pubTime":"2026-02-02 10:17","pubTimestamp":1769998622,"startTime":"0","endTime":"0","summary":"1月30日晚间,复旦张江发布2025年年度业绩预告。公告显示,公司当期业绩虽面临短期压力,但在创新药研发领域持续加码,ADC与光动力药物管线进展显著,为长期发展筑牢技术壁垒。研发投入的持续加大是复旦张江当期业绩承压的重要原因之一,公告披露,2025年其研发投入约3.5亿元,研发投入占营业收入比例持续上升,资源重点投向ADC与光动力药物等前沿治疗领域,多项核心项目取得关键进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202102907a6c83f9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202102907a6c83f9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01349"],"gpt_icon":0},{"id":"2607014795","title":"复旦张江(01349)发盈警 预计2025年度归母净亏损约1.2亿至1.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607014795","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607014795?lang=zh_cn&edition=full","pubTime":"2026-01-30 19:19","pubTimestamp":1769771965,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复旦张江 发布公告,集团预计截至2025年12月31日止年度将取得未经审核的归属于母公司所有者的净亏损约为人民币1.2亿元至1.8亿元;未经审核的归属于母公司所有者的扣除非经常性损益的净亏损约为人民币1.4亿元至2亿元。报告期内集团研发投入约人民币3.5亿元。与去年同期相比,该产品对集团的利润贡献同比减少约人民币1亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0239","01349","688505"],"gpt_icon":0},{"id":"2607039496","title":"复旦张江(688505)披露盐酸氨酮戊酸口服溶液用粉末获上市申请受理通知书,1月29日股价下跌0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607039496","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607039496?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:22","pubTimestamp":1769700133,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘,复旦张江报收于8.74元,较前一交易日下跌0.68%,最新总市值为90.6亿元。该股当日开盘8.81元,最高8.86元,最低8.71元,成交额达4885.71万元,换手率为0.78%。近日,上海复旦张江生物医药股份有限公司全资子公司泰州复旦张江药业有限公司收到国家药品监督管理局签发的《受理通知书》,盐酸氨酮戊酸口服溶液用粉末用于成人恶性高级别脑胶质瘤患者术中恶性组织可视化的药物上市申请已获受理。该事项对公司近期业绩无重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900044494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0239","01349","688505"],"gpt_icon":0},{"id":"2607700883","title":"复旦张江最新公告:盐酸氨酮戊酸口服溶液用粉末用于脑胶质瘤手术可视化获得药物上市申请受理通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2607700883","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607700883?lang=zh_cn&edition=full","pubTime":"2026-01-29 17:41","pubTimestamp":1769679682,"startTime":"0","endTime":"0","summary":"复旦张江(688505.SH)公告称,公司全资子公司泰州复旦张江药业有限公司收到国家药品监督管理局核准签发的《受理通知书》,盐酸氨酮戊酸口服溶液用粉末用于成人恶性高级别脑胶质瘤患者术中恶性组织可视化的药物上市申请获得受理。该药物未来如能获批上市,将进一步丰富公司的产品线,增强公司整体竞争力。但药品上市注册批件取得的时间和结果具有不确定性,该药物上市申请获得受理对公司近期业绩不会产生重大影响。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900030099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688505","BK1191","01349"],"gpt_icon":0},{"id":"2606714583","title":"复旦张江01月28日主力净流出186.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2606714583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606714583?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:16","pubTimestamp":1769588170,"startTime":"0","endTime":"0","summary":"01月28日, 复旦张江股价跌2.45%,报收3.19元,成交金额743.2万元,换手率0.70%,振幅4.59%,量比1.09。复旦张江今日主力资金净流出186.8万元,上一交易日主力净流入74.6万元。该股近5个交易日上涨5.28%,主力资金累计净流出133.4万元;近20日主力资金累计净流出139.7万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128163024a45f7ba4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128163024a45f7ba4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01349","BK1191"],"gpt_icon":0},{"id":"2606188209","title":"智通AH统计|1月27日","url":"https://stock-news.laohu8.com/highlight/detail?id=2606188209","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606188209?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:15","pubTimestamp":1769501707,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止1月27日收盘,东北电气、浙江世宝、京城机电股份分列AH溢价率前三位,溢价率分别为800.00%、351.95%、269.91%;宁德时代、招商银行、恒瑞医药分列AH溢价率末三位,溢价率分别为-12.95%、-3.26%、-2.69%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397895.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02009","00553","00300","LU0348816934.USD","01033","03750","02628","82318","03145","00042","01398","03143","01880","00638","01812","02338","HPAD.SI","01108","02359","02318","00317","02691","PNGAY","159982","002594","BYDDY","02218","PAImain","81211","01276","01528","03678","HYDD.SI","01877","03968","00358","399300","00187","06031","06185","01057","01618","01349","601318"],"gpt_icon":1},{"id":"2606296482","title":"港股异动 | 部分医药股午后拉升 康希诺生物(06185)超10% 君实生物(01877)涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606296482","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606296482?lang=zh_cn&edition=full","pubTime":"2026-01-26 13:44","pubTimestamp":1769406244,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,部分医药股午后拉升。截至发稿,康希诺生物涨10.13%,报40.86港元;君实生物涨5.19%,报23.92港元;复旦张江涨4.11%,报3.29港元。消息面上,1月26日,印度出现尼帕病毒疫情相关话题冲上热搜,引发关注。公开资料显示,尼帕是人畜共患的RNA病毒,主要由果蝠和猪携带,死亡率在40%至75%之间,潜伏期一般为4天至14天。目前尚无专门的疫苗和有效疗法,治疗侧重于控制症状和提供支持性护理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397208.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1161","BK1191","01877","688180","BK1583","09939","01349","BK0239","06185","BK1515","BK1574"],"gpt_icon":0},{"id":"2605417166","title":"部分银行黄金存款被抢光","url":"https://stock-news.laohu8.com/highlight/detail?id=2605417166","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605417166?lang=zh_cn&edition=full","pubTime":"2026-01-22 19:38","pubTimestamp":1769081895,"startTime":"0","endTime":"0","summary":"在黄金持续走强的背景下,挂钩黄金的结构性存款产品成为热门投资选择,不仅多家上市公司公告申购,部分银行甚至一度出现看涨黄金的结构性存款“售罄”。目前交行、招行、民生银行、中行、江苏银行、杭州银行等多家银行推出了结构性存款,部分银行看涨黄金的结构性存款额度一度紧张。高收益需满足相关条件尽管当前金价走势强劲,但银行推出的挂钩黄金结构性存款整体收益率水平并不突出。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122195736a449db39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122195736a449db39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01349","09608","BK1542","BK1229","BK1258"],"gpt_icon":0},{"id":"2605442871","title":"泰州复旦张江旗下产品LED光动力治疗仪拿到国家药监局审批的二类证","url":"https://stock-news.laohu8.com/highlight/detail?id=2605442871","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605442871?lang=zh_cn&edition=full","pubTime":"2026-01-22 12:41","pubTimestamp":1769056860,"startTime":"0","endTime":"0","summary":"产品名称:LED光动力治疗仪所属单位:泰州复旦张江产品类型:康复治疗设备审批机构:江苏省药品监督管理局证件类型:二类注册证编号:苏械注准20262090114获批时间:2026-01-19","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122124127a44847ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122124127a44847ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01349"],"gpt_icon":0},{"id":"2604186041","title":"智通AH统计|1月19日","url":"https://stock-news.laohu8.com/highlight/detail?id=2604186041","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604186041?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:15","pubTimestamp":1768810505,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止1月19日收盘,东北电气、浙江世宝、钧达股份分列AH溢价率前三位,溢价率分别为815.25%、384.97%、355.07%;宁德时代、恒瑞医药、招商银行分列AH溢价率末三位,溢价率分别为-11.36%、-4.80%、-0.84%。其中钧达股份、金风科技、三花智控的偏离值位居前三,分别为129.73%、38.82%、18.64%;另外,东北电气、晨鸣纸业、南华期货股份的偏离值位居后三,分别为-42.57%、-21.05%、-20.64%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394479.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03968","01349","00895","02628","01276","601318","01618","00300","00187","00638","HYDD.SI","06818","HPAD.SI","06869","002594","01057","159982","02691","BYDDY","03143","02338","82318","PAImain","00386","01033","PNGAY","03678","02318","06185","03750","399300","06613","00956","01812","06680","03606","03145","00042","01171","00553","81211","02218","02865","02359"],"gpt_icon":1},{"id":"2604925597","title":"每周股票复盘:复旦张江(688505)股东减持1036万股占总股本1.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604925597","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604925597?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:49","pubTimestamp":1768679346,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘,复旦张江报收于8.65元,较上周的8.84元下跌2.15%。本周,复旦张江1月12日盘中最高价报9.24元。本周关注点股本股东变化:股东杨宗孟减持10,365,721股,占总股本1.00%。股本股东变化股东增减持1月13日复旦张江发布公告,股东杨宗孟于2026年1月6日至2026年1月12日间合计减持794.88万股,占公司目前总股本的0.7668%。此前,杨宗孟持有公司64,009,773股,占总股本6.18%,减持后持股降至53,644,052股,占总股本5.18%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","688505","BK0239","01349"],"gpt_icon":0},{"id":"2603632904","title":"股市必读:1月13日复旦张江发布公告,股东减持794.88万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603632904","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603632904?lang=zh_cn&edition=full","pubTime":"2026-01-14 02:54","pubTimestamp":1768330451,"startTime":"0","endTime":"0","summary":"来自股本股东变化:股东杨宗孟在1月6日至1月12日期间合计减持794.88万股,占总股本的0.7668%。股本股东变化股东增减持1月13日复旦张江发布公告《复旦张江:复旦张江关于持股5%以上股东减持股份结果公告》,其股东杨宗孟于2026年1月6日至2026年1月12日间合计减持794.88万股,占公司目前总股本的0.7668%,变动期间该股股价上涨3.21%,截止1月12日收盘报9.0元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400001408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","688505","01349","BK0239"],"gpt_icon":0},{"id":"2603046805","title":"复旦张江:杨宗孟已减持1.00%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2603046805","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603046805?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:08","pubTimestamp":1768295295,"startTime":"0","endTime":"0","summary":"21智讯1月13日电,复旦张江公告,公司股东杨宗孟先生于2025年11月26日至2026年1月12日期间通过集中竞价交易方式累计减持公司股份10,365,721股,占公司总股本的1.00%。本次减持计划已实施完毕,减持价格区间为8.64至9.22元/股,减持总金额为9108.30万元。减持后,杨宗孟先生持有公司股份53,644,052股,持股比例由6.18%下降至5.18%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601133617421034.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","688505","BK1191","01349"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fd-zj.com","stockEarnings":[{"period":"1week","weight":-0.0182},{"period":"1month","weight":0.066},{"period":"3month","weight":0.1062},{"period":"6month","weight":-0.161},{"period":"1year","weight":0.2212},{"period":"ytd","weight":0.1619}],"compareEarnings":[{"period":"1week","weight":-0.0058},{"period":"1month","weight":-0.0065},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0424},{"period":"1year","weight":0.1699},{"period":"ytd","weight":0.0305}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海复旦张江生物医药股份有限公司是一家主要从事生物医药的研究开发、生产制造和市场营销业务的中国公司。该公司的产品包括盐酸氨酮戊酸外用散(商品名:艾拉)和注射用海姆泊芬(商品名:复美达),以及盐酸多柔比星脂质体注射液(商品名:里葆多)。其产品主要用于皮肤性病治疗和抗肿瘤治疗。该公司在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.384615,"avgChangeRate":0.001416},{"month":2,"riseRate":0.461538,"avgChangeRate":0.016876},{"month":3,"riseRate":0.416667,"avgChangeRate":0.030884},{"month":4,"riseRate":0.666667,"avgChangeRate":0.033877},{"month":5,"riseRate":0.5,"avgChangeRate":0.021392},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.036482},{"month":7,"riseRate":0.416667,"avgChangeRate":0.01229},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.050954},{"month":9,"riseRate":0.5,"avgChangeRate":0.011457},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.009053},{"month":11,"riseRate":0.583333,"avgChangeRate":0.018301},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.017318}],"exchange":"SEHK","name":"复旦张江","nameEN":"FUDANZHANGJIANG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"复旦张江(01349)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供复旦张江(01349)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"复旦张江,01349,复旦张江股票,复旦张江股票老虎,复旦张江股票老虎国际,复旦张江行情,复旦张江股票行情,复旦张江股价,复旦张江股市,复旦张江股票价格,复旦张江股票交易,复旦张江股票购买,复旦张江股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"复旦张江(01349)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供复旦张江(01349)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}